119 related articles for article (PubMed ID: 12416025)
1. Hexadecylphosphocholine does not influence phospholipase D and sphingomyelinase activity in human leukemia cells.
Berkovic D; Berkovic K; Binder C; Haase D; Fleer EA
J Exp Ther Oncol; 2002; 2(4):213-8. PubMed ID: 12416025
[TBL] [Abstract][Full Text] [Related]
2. Hexadecylphosphocholine inhibits phosphatidylinositol and phosphatidylcholine phospholipase C in human leukemia cells.
Berkovic D; Goeckenjan M; Lüders S; Hiddemann W; Fleer EA
J Exp Ther Oncol; 1996 Sep; 1(5):302-11. PubMed ID: 9414418
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of phospholipase A2 in human leukemia cells by the etherphospholipid analogue hexadecylphosphocholine.
Berkovic D; Lüders S; Goeckenjan M; Hiddemann W; Fleer EA
Biochem Pharmacol; 1997 Jun; 53(11):1725-33. PubMed ID: 9264326
[TBL] [Abstract][Full Text] [Related]
4. Effects of hexadecylphosphocholine on phosphatidylcholine and phosphatidylserine metabolism in human lymphoma cells.
Berkovic D; Sievers S; Haase D; Fleer EA; Binder C
J Exp Ther Oncol; 2002; 2(2):85-92. PubMed ID: 12415624
[TBL] [Abstract][Full Text] [Related]
5. Hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis and the proliferation of HepG2 cells.
Jiménez-López JM; Carrasco MP; Segovia JL; Marco C
Eur J Biochem; 2002 Sep; 269(18):4649-55. PubMed ID: 12230578
[TBL] [Abstract][Full Text] [Related]
6. Miltefosine inhibits the membrane remodeling caused by phospholipase action by changing membrane physical properties.
Zulueta Díaz YLM; Ambroggio EE; Fanani ML
Biochim Biophys Acta Biomembr; 2020 Oct; 1862(10):183407. PubMed ID: 32628918
[TBL] [Abstract][Full Text] [Related]
7. Modulation of phospholipase D by hexadecylphosphorylcholine: a putative novel mechanism for its antitumoral activity.
Lucas L; Hernández-Alcoceba R; Penalva V; Lacal JC
Oncogene; 2001 Mar; 20(9):1110-7. PubMed ID: 11314048
[TBL] [Abstract][Full Text] [Related]
8. The antitumor phospholipid analog, hexadecylphosphocholine, activates cellular phospholipase D.
Wieder T; Zhang Z; Geilen CC; Orfanos CE; Giuliano AE; Cabot MC
Cancer Lett; 1996 Feb; 100(1-2):71-9. PubMed ID: 8620456
[TBL] [Abstract][Full Text] [Related]
9. The interference effects of hexadecylphosphocholine on proliferation and membrane phospholipid metabolism in human myeloid leukemia cell lines.
Wang YZ; Chang YB; Xing C; Fu D
Int J Tissue React; 1998; 20(3):101-7. PubMed ID: 9894183
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.
Berkovic D; Berkovic K; Fleer EA; Eibl H; Unger C
Eur J Cancer; 1994; 30A(4):509-15. PubMed ID: 8018410
[TBL] [Abstract][Full Text] [Related]
11. Phospholipid analogue hexadecylphosphocholine inhibits proliferation and phosphatidylcholine biosynthesis of human epidermal keratinocytes in vitro.
Detmar M; Geilen CC; Wieder T; Orfanos CE; Reutter W
J Invest Dermatol; 1994 Apr; 102(4):490-4. PubMed ID: 8151126
[TBL] [Abstract][Full Text] [Related]
12. Effects of hexadecylphosphocholine on membrane phospholipid metabolism in human tumour cells.
Berkovic D; Grunwald U; Menzel W; Unger C; Hiddemann W; Fleer EA
Eur J Cancer; 1995 Nov; 31A(12):2080-5. PubMed ID: 8562169
[TBL] [Abstract][Full Text] [Related]
13. The phospholipid analogue hexadecylphosphocholine (HePC) inhibits proliferation of keloid fibroblasts in vitro and modulates their fibronectin and integrin synthesis.
Blume-Peytavi U; Geilen CC; Sommer C; Almond-Roesler B; Orfanos CE
Arch Dermatol Res; 1997 Feb; 289(3):164-9. PubMed ID: 9128765
[TBL] [Abstract][Full Text] [Related]
14. Effects of hexadecylphosphocholine on thrombocytopoiesis.
Berkovic D; Bensch M; Bertram J; Wille T; Haase D; Binder C; Fleer EA
Eur J Cancer; 2001 Mar; 37(4):503-11. PubMed ID: 11267861
[TBL] [Abstract][Full Text] [Related]
15. The effect of hexadecylphosphocholine on the degradation of mitochondrial phospholipids.
Vagina O; Gellerich FN; Ulbrich-Hofmann R
Mol Cell Biochem; 1998 Jun; 183(1-2):169-73. PubMed ID: 9655193
[TBL] [Abstract][Full Text] [Related]
16. Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine.
Wieder T; Orfanos CE; Geilen CC
J Biol Chem; 1998 May; 273(18):11025-31. PubMed ID: 9556584
[TBL] [Abstract][Full Text] [Related]
17. Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues.
Berkovic D; Haase D; Hiddemann W; Fleer EA
J Exp Ther Oncol; 1996 Nov; 1(6):368-75. PubMed ID: 9414427
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of human hematopoietic progenitor cells by the alkylphosphocholines hexadecylphosphocholine and hexadecyl-N,N,N-trimethyl-hexanolamine.
Ergezinger K; Vehmeyer K; Unger C
Anticancer Res; 1999; 19(4B):3213-9. PubMed ID: 10652614
[TBL] [Abstract][Full Text] [Related]
19. Hexadecylphosphocholine inhibits invasion of mouse T-cell lymphoma cells in two different invasion assays.
Schaider H; Seidl H; Berger MR; Hofmann-Wellenhof R; Tritthart HA; Smolle J
Anticancer Res; 1998; 18(2A):995-8. PubMed ID: 9615753
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferation effects of hexadecylphosphocholine on solid tumour and leukaemia selectively in vitro.
Wang YZ; Liu XY; Wu LJ; Zhang YB; Hou L; Xu QS
Drugs Exp Clin Res; 1997; 23(3-4):97-102. PubMed ID: 9403269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
